Fierce Pharma

OCTOBER 31, 2023

Even as Catalent dusts itself off from a pandemic sales plunge, the company may be teetering on the edge of another contract manufacturing precipice.

Gene Therapy 55

Gene Therapy Gene Contract Manufacturing Trials 55

pharmaphorum

MARCH 4, 2022

Novo Nordisk’s rollout of obesity therapy Wegovy has been beset by production problems, but the company says these are being resolved and it now anticipates it will help drive obesity sales to 25 billion kroner ($3.69 Additional manufacturing capacity will also come online in 2023, said Sylvest. US sales of the pair same in at 4.9

Sales 64

Sales Contract Manufacturing Manufacturing Marketing 64

Pharmaceutical Technology

JULY 15, 2022

The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. The documents state that a partnership with a CMO would be cheaper than the state directly manufacturing insulin. Prices would be “a fraction of the $300 per vial prices charged by insulin manufacturers.”.

Insulin 328

Insulin Manufacturing Contract Manufacturing Production 328

Pharmaceutical Technology

NOVEMBER 9, 2022

Ozempic has been plagued by a shortage fueled by demand, and Wegovy has had contract-manufacturing-related supply chain issues, but that hasn’t prevented Novo’s GLP-1 franchise from achieving overall sales growth of 44% for the first nine months of the year.

Contract Manufacturing 130

Contract Manufacturing Sales Marketing Manufacturing 130

Pharmaceutical Technology

SEPTEMBER 14, 2022

Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Contract marketing companies build a strong sales and marketing team rapidly and save efforts and time on the recruitment process.

Marketing 100

Marketing Contract Manufacturing Sales Clinical Trials 100

Drug Discovery World

SEPTEMBER 5, 2022

South Korea recovered from the pandemic earlier than many other Asian countries and reported rapid growth in its contract manufacturing industry in the last two years. . The results of the survey were revealed ahead of CPHI Korea, which will be held in Seoul, September 28-30.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Sales Marketing 52

The Pharma Data

JULY 22, 2021

Beyond dental and through its Novocol Pharma division, the group also partners with pharmaceutical and medical device companies to provide contract manufacturing services for pharmaceutical products that require cartridge filling. The group counts 1,900 employees and has a long-established presence in more than 150 countries.

Branding 52

Branding Production Sales Contract Manufacturing 52

BioPharma Reporter

AUGUST 21, 2023

Novartisâ board of directors has unanimously agreed to separate Sandoz as a 100 per cent spin-off with a $15 billion share buyback.

Sales 97

Sales Contract Manufacturing Manufacturing 97

Pharmaceutical Technology

JUNE 6, 2023

Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). It also provides sterile injectable pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services.

Contract Manufacturing 100

Contract Manufacturing Manufacturing Production Pharmacy 100

The Pharma Data

AUGUST 3, 2021

In the first six months, the company generated net sales of 9.8 All three business areas (Human Pharma, Animal Health, Biopharmaceutical Contract Manufacturing) contributed to the net sales growth. Human Pharma: JARDIANCE ® and OFEV ® growth driver s In Human Pharma, Boehringer Ingelheim achieved net sales of 7.1

Development 52

Development Research Contract Manufacturing Sales 52

Roots Analysis

FEBRUARY 27, 2024

What are the financial terms of the agreement: Ambrx is likely to receive an undisclosed upfront payment, development milestones, and a double-digit royalty on product sales in China. NovoCodex is also eligible to share an undisclosed portion of ARX305 product sales outside of China. Check the details of the agreement here.

Antibody 40

Antibody Marketing Drugs Contract Manufacturing 40

Pharmaceutical Technology

MAY 26, 2023

The acquisition targets had a wide variety of manufacturing services, including API and dose manufacturing, packaging, and analytical services. Although there is a slight dip in M&A activity in 2022 compared to 2021, it is still higher than levels in 2018–2020.

Life Science 130

Life Science Manufacturing Contract Manufacturing Gene Therapy 130

XTalks

JANUARY 29, 2021

Several oncology products now have “blockbuster” status where sales exceed $1 billion annually. Merck’s Keytruda ($7.2B) and BMS’s Opdivo ($1.8B) hold the number 2 and number 11 spots, respectively, in annual sales of the top oncology products. Keytruda (Pembrolizumab) and Opdivo (Nivolumab).

Clinical Trials 104

Clinical Trials Clinical Trials Production Trials 104

Roots Analysis

FEBRUARY 26, 2024

In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com. You can also download the SAMPLE REPORT on subcutaneous medications by Roots Analysis.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs Contract Manufacturing 52

Pharmaceutical Technology

JANUARY 30, 2023

This is mixed news for contract manufacturing organisations (CMOs), as large CMOs such as Thermo Fisher Scientific (Waltham, MA, US) and Catalent Inc (Somerset, NJ, US) are typically involved in the manufacture of the most innovative products. However, non-NME and biosimilar approvals increased in 2022.

Drugs 130

Drugs Manufacturing Contract Manufacturing FDA Approval 130

The Pharma Data

MARCH 29, 2023

Medicines reached a record 30 million people, driven by JARDIANCE® and OFEV® R&D investments of 5 billion EUR, or 21 percent of net sales Net sales rise 10.5 Medicines reached a record 30 million people, driven by JARDIANCE® and OFEV® R&D investments of 5 billion EUR, or 21 percent of net sales Net sales rise 10.5

Medicine 40

Medicine Sales Contract Manufacturing Production 40

pharmaphorum

NOVEMBER 5, 2020

Tagrisso is the top-selling EGFR inhibitor, with sales of almost $3.2 billion last year, while Keytruda dominates the market for cancer immunotherapies for NSCLC, accounting for a large chunk of its $11 billion-plus 2019 sales tally. Both studies are due to start in the first half of next year.

Gene Therapy 98

Gene Therapy Gene Drugs Contract Manufacturing 98

Pharmaceutical Technology

JULY 29, 2022

In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contract manufacturing organisations (CMOs). A nitrogen-binding drug, its global sales were $292m in 2021, as per GlobalData. Other treatments include sodium phenylbutyrate marketed as Buphenyl or Ammonaps.

RNA 245

RNA Gene Expression Gene Gene Therapy 245

The Pharma Data

MARCH 24, 2021

of net sales). Outlook 2021: slight year-on-year increase in net sales on a comparable basis. All of its businesses contributed positively to net sales and operating income. The company recorded net sales of 19.57 Foreign currency headwinds had a considerable impact; adjusted for currency effects, net sales rose by 5.6%

Sales 52

Sales Contract Manufacturing Medicine Antibody 52

pharmaphorum

JULY 7, 2021

Three months ago, the FDA said it was unconvinced by a bridging study designed to show equivalence between Provention’s product intended for commercial sale, made by contract manufacturer AGC Biologics, and the drug that teplizumab’s original developer Eli Lilly used in clinical trials.

Drugs 98

Drugs Insulin Contract Manufacturing Antibody 98

pharmaphorum

FEBRUARY 8, 2022

Nevertheless, the decision by NICE to back routine NHS use of Wegovy is a win for Novo Nordisk, which has been hit by supply constraints linked to a contract manufacturer for the drug that have affect its rollout in the US, where it was approved last June.

Drugs 105

Drugs Contract Manufacturing Clinical Trials Clinical Trials 105

pharmaphorum

DECEMBER 18, 2020

Over that period sales have grown steadily to reach £514 million (almost $700 million) in the first nine months of 2020, boosted by its position as the only biologic approved to treat SLE. Approval in lupus nephritis is expected to push the product above the $1 billion threshold and into blockbuster sales territory.

FDA Approval 82

FDA Approval Contract Manufacturing Sales Trials 82

pharmaphorum

NOVEMBER 2, 2020

Once formed, Viatris will be a generics behemoth with annual sales of around $19 to $20 billion and operations in 165 markets around the word. Upjohn is now due to be spun off from Pfizer on 13 November, with the merger concluding three days later – around 16 months after first being announced.

Generic Drugs 52

Generic Drugs Contract Manufacturing Production Manufacturing 52

pharmaphorum

MARCH 21, 2022

Prior to the FDA rejection , GlobalData was predicting global peak sales of $691 million for teplizumab in 2027. Now, the regulator has accepted the resubmission, kicking off another six-month review period as teplizumab has previously been awarded breakthrough status.

Drugs 52

Drugs Insulin Contract Manufacturing Clinical Trials 52

pharmaphorum

NOVEMBER 18, 2022

The agency said at the time it was unconvinced by a bridging study designed to show equivalence between Provention’s product – made by contract manufacturer AGC Biologics – and the drug that teplizumab’s original developer Eli Lilly used in clinical trials.

Drugs 52

Drugs FDA Approval Insulin Clinical Trials 52

XTalks

APRIL 11, 2024

J&J has ambitious plans for Carvykti as it is looking to target peak product sales of over $5 billion for the therapy. In 2023, the drug’s sales totalled $500 million. In last month’s call, Legend CEO Ying Huang, PhD, shared that the partners are aiming to increase manufacturing capacity at their New Jersey plant.

FDA Approval 52

FDA Approval Manufacturing Trials Clinical Trials 52

pharmaphorum

AUGUST 11, 2021

There has been a facility inspection carried out by the FDA at the contract manufacturer for the drug, but Axsome said it was unaware of any ‘Form 483’ issues – when inspectors see conditions they deem to be objectionable.

Drugs 52

Drugs Contract Manufacturing Marketing Clinical Trials 52

The Pharma Data

OCTOBER 12, 2021

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Boehringer Ingelheim.

Medicine 52

Medicine Contract Manufacturing Production Research 52

The Pharma Data

JANUARY 5, 2021

Novasep’s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA , China and India. 6,200 people, and earned sales revenue of 1,440.6 million euros.

Manufacturing 52

Manufacturing Sales Contract Manufacturing Insulin 52

The Pharma Data

MARCH 22, 2022

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Boehringer Ingelheim. Source link: [link] /.

Research 52

Research Contract Manufacturing Scientist Medicine 52

The Pharma Data

NOVEMBER 5, 2020

is a rapidly growing generic pharmaceutical company in the United States devoted to discovery, manufacture, sale, and distribution of prescription generic pharmaceutical products. About Jubilant Cadista Pharmaceuticals Inc. Jubilant Cadista Pharmaceuticals Inc. View original content to download multimedia: [link].

Marketing 40

Marketing Generic Pharmaceutical Contract Manufacturing Manufacturing 40

The Pharma Data

JANUARY 24, 2021

(TSXV: THRM) (“Therma Bright” or the “Company”), a progressive medical device technology company announces that it has taken 100% control of the research and development, regulatory, manufacturing and commercialization of its saliva-based rapid antigen test. The securities have not been registered under the U.S.

Sales 52

Sales Manufacturing Contract Manufacturing Containment 52

The Pharma Data

JULY 29, 2021

Following the completion of the spin-off of the Upjohn Business(6) in the fourth quarter of 2020, Pfizer operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products worldwide. Revenues $78.0 billion (previously $70.5

Manufacturing 52

Manufacturing Sales Contract Manufacturing Vaccination 52

XTalks

JANUARY 23, 2024

This venture also led me to identify a gap in the market for contract manufacturing of recombinant proteins. Our strategy involves closely working with pediatric endocrinologists and a targeted sales force, potentially enabling us to efficiently cover markets like the US.

Development 72

Development Hormones Drugs Trials 72

The Pharma Data

NOVEMBER 5, 2020

net sales increased 11% to $1.32 Third quarter 2020 Dupixent ® global net sales (2) , which are recorded by Sanofi, increased 69% to $1.07 “This is evidenced by Dupixent achieving in excess of $1 billion in global net sales this quarter.” Cost of collaboration and contract manufacturing (COCM). $.

Sales 52

Sales Production Manufacturing Antibody 52

The Pharma Data

MARCH 16, 2021

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros.

Development 52

Development Contract Manufacturing Licensing Licensing 52

The Pharma Data

MARCH 2, 2021

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros.

In-Vivo 52

In-Vivo Contract Manufacturing Bioinformatics Clinical Development 52